Skip to main content
CARE
NASDAQ Finance

Carter Bankshares Details $98M Gain from Major Loan Sale, Boosting Q1 EPS by $3.50

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Bank Stocks · Financial
Sentiment info
Positive
Importance info
9
Price
$25.88
Mkt Cap
$573.5M
52W Low
$15.035
52W High
$26.13
52W Position info
72% above low
Off High info
at 52W high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

CARE sits 72% above its 52-week low of $15.035.

Summary

Carter Bankshares, Inc. disclosed the detailed financial impact of resolving its largest nonperforming loan, reporting a $98.0 million gain and a $3.50 diluted EPS boost for Q1 2026, significantly improving asset quality and earnings.


Key Events · M&A and Partnerships · CARE

  • Quantified Impact of Major Loan Sale

    The company reported a total gain, recovery, and reserve release of $98.0 million from the successful resolution of its largest legacy nonperforming credit relationship on March 26, 2026.

  • Significant Q1 EPS Boost

    The transaction contributed $77.4 million to net income after tax, resulting in a $3.50 diluted earnings per share impact for the first quarter of 2026.

  • Improved Asset Quality

    The resolution of the nonperforming loan significantly reduced the Nonperforming Loans (NPLs) to Total Portfolio Loans ratio to 0.64% and improved other asset quality metrics.

  • Strong Overall Q1 2026 Financials

    The company reported a GAAP Q1 2026 diluted EPS of $3.88, a Return on Average Assets (ROA) of 7.13%, and a Return on Average Shareholders' Equity (ROE) of 80.05%, with these figures significantly boosted by the transaction.


Analysis · CARE · Finance

This 8-K filing, through its investor presentation, provides critical financial details regarding the previously announced resolution of Carter Bankshares' largest nonperforming credit relationship. The quantified $98.0 million gain, recovery, and reserve release from this transaction, which translates to a $3.50 diluted EPS impact, represents a substantial positive development. This event significantly de-risks the balance sheet, improves asset quality, and dramatically boosts Q1 2026 earnings, reinforcing the company's strong financial performance as it trades near its 52-week high. This detailed quantification is new and highly material information for investors.

At the time of this filing, CARE was trading at $25.88 on NASDAQ in the Finance sector, with a market capitalization of approximately $573.5M. The 52-week trading range was $15.04 to $26.13. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CARE - Latest Insights

CARE
Jul 23, 2026, 8:22 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $32.66
Real-time Price: $34.58 info
Change: +$1.92 (+6%) info
Market Cap: $766.369M info
CARE
Jul 23, 2026, 8:14 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $32.66
Real-time Price: $34.58 info
Change: +$1.92 (+6%) info
Market Cap: $766.369M info
CARE
May 29, 2026, 5:19 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $27.30
Real-time Price: $34.58 info
Change: +$7.28 (+27%) info
Market Cap: $766.369M info
CARE
May 07, 2026, 1:33 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $26.22
Real-time Price: $34.58 info
Change: +$8.36 (+32%) info
Market Cap: $766.369M info
CARE
May 01, 2026, 9:33 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $25.60
Real-time Price: $34.58 info
Change: +$8.98 (+35%) info
Market Cap: $766.369M info